A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)
Public ClinicalTrials.gov record NCT04477707. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Observational Study of Routine Ophthalmological Examinations of Patients Included in the 2 Bayer Sponsored Phase 3 Clinical Trials FIDELIO and FIGARO to Investigate the Effect of Finerenone on Delaying the Progression of Diabetic Retinopathy
Study identification
- NCT ID
- NCT04477707
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 206 participants
Conditions and interventions
Conditions
Interventions
- Finerenone (BAY94-8862) Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 22, 2020
- Primary completion
- Jun 24, 2021
- Completion
- Jun 24, 2021
- Last update posted
- Jun 28, 2022
2020 – 2021
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Institute of Renal Research - Chula Vista | Chula Vista | California | 91910 | — |
| California Institute of Renal Research, Inc. - El Centro | El Centro | California | 92243 | — |
| Elixia at Florida Kidney Physicians Southeast | Fort Lauderdale | Florida | 33308 | — |
| John H Stroger Jr. Hospital of Cook County | Chicago | Illinois | 60612 | — |
| Crescent City Clinical Research Center, LLC | Metairie | Louisiana | 70006 | — |
| Joslin Diabetes Center | Boston | Massachusetts | 02215 | — |
| Kansas City VA Medical Center | Kansas City | Missouri | 64128 | — |
| Office of Osvaldo A. Brusco, MD | Corpus Christi | Texas | 78414 | — |
| MedResearch, Inc. | El Paso | Texas | 79902-4672 | — |
| Clinical Advancement Center, PLLC | San Antonio | Texas | 78212-4740 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04477707, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04477707 live on ClinicalTrials.gov.